Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 106.63 M93.24 M — Research & development 25.05 M21.62 M — Operating income -17.99 M32.64 M — Non-Operating Income, Total -53.8 M-8.32 M — Interest expense, net of interest capitalized 19.21 M13.51 M — Non-Operating Income, excl. Interest Expenses -54.67 M-21.73 M — Unusual income/expense -18.34 M-89 K — Pretax income 71.79 M24.32 M — Equity in earnings —— — Taxes 00 — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -71.79 M24.32 M — Discontinued operations —— — Net income -71.79 M24.32 M — Dilution adjustment 1.03 B0 — Preferred dividends 445.41 M0 — Diluted net income available to common stockholders 517.2 M24.32 M — Basic earnings per share (Basic EPS) -7.970.09 — Diluted earnings per share (Diluted EPS) -7.970.08 — Average basic shares outstanding 64.92 M282.1 M — Diluted shares outstanding 64.92 M297.21 M — EBITDA —— — EBIT —— — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 6.4 M4.9 M —